ARTHEx Biotech – Meet the DM Drug Developers 2025

Originally presented on August 1st, 2025.

ARTHEx Biotech presents an update on their DM program, including the ATX-01 program for DM1 and an overview of the ArthemiR trial. Click here to learn more about ARTHEx Biotech.

Presenters include:

• Beatriz Llamusi, PhD, Chief Scientific Officer & Co-Founder
• Judy Walker, MD, Chief Medical Officer

Register once and you can join any of our 2025 Meet the DM Drug Developer webinars! Click here to find all our upcoming Meet the DM Drug Developer dates and previously recorded sessions. >>>

Questions or comments? Contact MDF at 415-800-7777 or at info@myotonic.org.

 

 

Thank you to our 2025 Community Education Webinar Series Sponsors, Avidity Biosciences and Dyne Therapeutics!

MDF Resources referenced in this video:

• Toolkits & Publications
• Support Groups
• Calendar of Events
• DM Drug Development Pipeline
• Myotonic Dystrophy Family Registry
• Ask the Expert series
• Study & Trial Resource Center
• Sign up for My Dispatch, our monthly e-newsletter!